A Dosage-dependent Manner of Botulinum Toxin Type A on the Prevention of Postoperative Scars of Various Anatomic Regions of the Body
Clinical trial NCT06349733 · COMPLETED
Trial details
- NCT number
- NCT06349733
- Sponsor
- Qilu Hospital of Shandong University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2023-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.